Physician profile
Jacob Connelly
NPI 1598184517
$7,833.37
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $4,135 · 2021: $3,155 · 2022: $170 · 2023: $331 · 2024: $42.66.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $374.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $373.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $4,173.50 | 2020-2024 | Bioinductive Implant With Arthroscopic Delivery System - Medium, Lens 4k, Journey II |
| Arthrex, INC. | $1,893.00 | 2021 | |
| Southern Edge Orthopaedics, INC. | $1,236.98 | 2021-2023 | |
| Zimmer Biomet Holdings, INC. | $149.84 | 2022 | |
| Bioventus LLC | $145.32 | 2020 | |
| Medacta USA, INC. | $92.00 | 2023 | Reverse Shoulder |
| Stryker Corporation | $53.15 | 2023 | Insignia |
| Vericel Corporation | $45.51 | 2023-2024 | Maci |
| Depuy Synthes Sales INC. | $30.06 | 2023 | Monovisc |
| Pacira Pharmaceuticals Incorporated | $14.01 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacob Connelly listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.